Have a personal or library account? Click to login
In Silico Insights into the Efficacy of Darjeeling Himalaya’s Traditional Fermented Beverages To Combat Various High-Altitude Sicknesses Cover

In Silico Insights into the Efficacy of Darjeeling Himalaya’s Traditional Fermented Beverages To Combat Various High-Altitude Sicknesses

Open Access
|Jan 2024

References

  1. Acharyya, S., Saha, S., Majumder, S., & Bhattacharya, M. (2021). Characterization of a mercury tolerant strain of Staphylococcus arlettae from Darjeeling hills with an account of its antibiotic resistance pattern and metabolome. Archives of Microbiology, 203, 5745-5754.
  2. Al Azzam, K. M., Negim, E. S., & Aboul-Enein, H. Y. (2022). ADME studies of TUG-770 (a GPR-40 inhibitor agonist) for the treatment of type 2 diabetes using SwissADME predictor: In silico study. Journal of Applied Pharmaceutical Science, 12(4), 159-169.
  3. Amin, M. L. (2013). P-glycoprotein inhibition for optimal drug delivery. Drug Target Insights, 7, DTIS12519.
  4. Arabi, M., Nasab, S. H., Lorigooini, Z., Boroujeni, S. N., Mortazavi, S. M., Anjomshoa, M., & Amini-Khoei, H. (2021). Auraptene exerts protective effects on maternal separation stress-induced changes in behavior, hippocampus, heart and serum of mice. International Immunopharmacology, 93, 107436.
  5. Bibak, B., Shakeri, F., Barreto, G. E., Keshavarzi, Z., Sathyapalan, T., & Sahebkar, A. (2019). A review of the pharmacological and therapeutic effects of auraptene. BioFactors, 45(6), 867-879.
  6. Bogaki, T., Mitani, K., Oura, Y., & Ozeki, K. (2017). Effects of ethyl-α-d-glucoside on human dermal fibroblasts. Bioscience, Biotechnology, and Biochemistry, 81(9), 1706-1711.
  7. Borgström, L. (1998). Local versus total systemic bioavailability as a means to compare different inhaled formulations of the same substance. Journal of Aerosol Medicine, 11(1), 55-63.
  8. Buels, K. S., & Fryer, A. D. (2012). Muscarinic receptor antagonists: effects on pulmonary function. Muscarinic Receptors, 317-341.
  9. Chandramoorthi, G. D., Piramanayagam, S., & Marimuthu, P. (2008). An insilico approach to high altitude pulmonary edema-molecular modeling of human β2 adrenergic receptor and its interaction with salmeterol and nifedipine. Journal of Molecular Modeling, 14, 849-856.
  10. Chauhan, G., Roy, K., Kumar, G., Kumari, P., Alam, S., Kishore, K., Panjwani, U., & Ray, K. (2019). Distinct influence of COX-1 and COX-2 on neuroinflammatory response and associated cognitive deficits during high altitude hypoxia. Neuropharmacology, 146, 138-148.
  11. Chen, J. F., Eltzschig, H. K., & Fredholm, B. B. (2013). Adenosine receptors as drug targets—what are the challenges?. Nature reviews Drug discovery, 12(4), 265-286.
  12. Chen, P. Z., He, W. J., Zhu, Z. R., Guo-Ji, E., Xu, G., Chen, D. W., & Gao, Y. Q. (2018a). Adenosine A2A receptor involves in neuroinflammation-mediated cognitive decline through activating microglia under acute hypobaric hypoxia. Behavioural Brain Research, 347, 99-107.
  13. Chen, C. P., Chen, C. C., Huang, C. W., & Chang, Y. C. (2018b). Evaluating molecular properties involved in transport of small molecules in stratum corneum: A quantitative structure-activity relationship for skin permeability. Molecules, 23(4), 911.
  14. Choi, S. H., Aid, S., & Bosetti, F. (2009). The distinct roles of cyclooxygenase-1 and-2 in neuroinflammation: implications for translational research. Trends in Pharmacological Sciences, 30(4), 174-181.
  15. Cieślak, M., Komoszyński, M., & Wojtczak, A. (2008). Adenosine A 2A receptors in Parkinson’s disease treatment. Purinergic Signalling, 4, 305-312.
  16. Clarke C. (2006). Acute mountain sickness: medical problems associated with acute and subacute exposure to hypobaric hypoxia. Postgraduate Medical Journal, 82(973), 748–753. https://doi.org/10.1136/pgmj.2006.047662
  17. Daina, A., & Zoete, V. (2016). A boiled‐egg to predict gastrointestinal absorption and brain penetration of small molecules. ChemMedChem, 11(11), 1117-1121.
  18. Ericsson, C. D., Steffen, R., Basnyat, B., Cumbo, T. A., & Edelman, R. (2001). Infections at high altitude. Clinical Infectious Diseases, 33(11), 1887-1891.
  19. Ferrazzini, G., Maggiorini, M., Kriemler, S., Bärtsch, P., & Oelz, O. (1987). Successful treatment of acute mountain sickness with dexamethasone. British Medical Journal (Clinical Research Ed..), 294(6584), 1380-1382.
  20. Ferro, J. N. D. S., de Aquino, F. L. T., de Brito, R. G., dos Santos, P. L., Quintans, J. D. S. S., de Souza, L. C., de Araújo, A. F., Diaz, B. L., Lucca‐Júnior, W., Quintans‐Júnior, L. J., & Barreto, E. (2015). Cyclo‐ Gly‐Pro, a cyclic dipeptide, attenuates nociceptive behaviour and inflammatory response in mice. Clinical and Experimental Pharmacology and Physiology, 42(12), 1287-1295.
  21. Ghose, A. K., Herbertz, T., Hudkins, R. L., Dorsey, B. D., & Mallamo, J. P. (2012). Knowledge-based, central nervous system (CNS) lead selection and lead optimization for CNS drug discovery. ACS Chemical Neuroscience, 3(1), 50-68.
  22. Ghosh, A., Chakraborty, S., Majumder, S., & Bhattacharya, M. (2022). Comprehensive In silico Investigation Validates Two Flavonoid Compounds of Derris robusta (Roxb. ex DC.) Benth. to Supplant Remdesivir as Natural Therapeutic Remedy Against a Range of Coronaviruses. Letters in Applied NanoBioscience, 12, 4, 108
  23. Gibson, G. E., & Duffy, T. E. (1981). Impaired synthesis of acetylcholine by mild hypoxic hypoxia or nitrous oxide. Journal of Neurochemistry, 36(1), 28-33.
  24. Graczyk, M., Przybyszewski, M., Kuźmiński, A., Tlappa, J., Mućka, J., Napiórkowska, K., Szynkiewicz, E., Żbikowska-Gotz, M., & Bartuzi, Z. (2013). Role of E-selectin and platelet endothelial cell adhesion molecule 1 in gastritis in food allergy patients. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 30(5), 271-276.
  25. Gupta, M., Lee, H. J., Barden, C. J., & Weaver, D. F. (2019). The blood–brain barrier (BBB) score. Journal of Medicinal Chemistry, 62(21), 9824-9836.
  26. Hackett, P., Rennie, D., & Levine, H. (1976). The incidence, importance, and prophylaxis of acute mountain sickness. The Lancet, 308(7996), 1149-1155.
  27. Hitchcock, S. A. (2012). Structural modifications that alter the P-glycoprotein efflux properties of compounds. Journal of Medicinal Chemistry, 55(11), 4877-4895.
  28. Imray, C., Wright, A., Subudhi, A., & Roach, R. (2010). Acute mountain sickness: pathophysiology, prevention, and treatment. Progress in Cardiovascular Diseases, 52(6), 467-484.
  29. Jacome-Sosa, M., Vacca, C., Mangat, R., Diane, A., Nelson, R.C., Reaney, M. J., Shen, J., Curtis, J. M., Vine, D. F., Field, C. J., & Igarashi, M. (2016). Vaccenic acid suppresses intestinal inflammation by increasing anandamide and related N-acylethanolamines in the JCR: LA-cp rat [S]. Journal of Lipid Research, 57(4), 638-649.
  30. Janoff, E. N., Rubins, J. B., Fasching, C., Charboneau, D., Rahkola, J. T., Plaut, A. G., & Weiser, J. N. (2014). Pneumococcal IgA1 protease subverts specific protection by human IgA1. Mucosal Immunology, 7(2), 249-256.
  31. Johnson, T. S., Rock, P. B., Fulco, C. S., Trad, L. A., Spark, R. F., & Maher, J. T. (1984). Prevention of acute mountain sickness by dexamethasone. New England Journal of Medicine, 310(11), 683-686.
  32. Jung, W. C., Jang, Y. J., Kim, J. H., Park, S. S., Park, S. H., Kim, S. J., Mok, Y. J., & Kim, C.S. (2012). Expression of intercellular adhesion molecule-1 and e-selectin in gastric cancer and their clinical significance. Journal of Gastric Cancer, 12(3), 140-148.
  33. Juvale, I. I. A., Hamid, A. A. A., Abd Halim, K. B., & Has, A. T. C. (2022). P-glycoprotein: new insights into structure, physiological function, regulation and alterations in disease. Heliyon, e09777.
  34. Kapoor, R., Narula, A. S., & Anand, A. C. (2004). Treatment of acute mountain sickness and high altitude pulmonary oedema. Medical Journal Armed Forces India, 60(4), 384-387.
  35. Kishimoto, T. (2005). Interleukin-6: from basic science to medicine—40 years in immunology. Annual Review of Immunology, 23, 1-21.
  36. Laskowski, R. A., & Swindells, M. B. (2011). LigPlot+: multiple ligand–protein interaction diagrams for drug discovery. Journal of Chemical Information and Modeling, 51 (10), 2778-2786
  37. Li, L., Yu, A. L., Wang, Z. L., Chen, K., Zheng, W., Zhou, J. J., Xie, Q., Yan, H. B., Ren, P., & Huang, X. (2019). Chaihu-Shugan-San and absorbed meranzin hydrate induce anti-atherosclerosis and behavioral improvements in high-fat diet ApoE-/-mice via anti-inflammatory and BDNF-TrkB pathway. Biomedicine & Pharmacotherapy, 115, p.108893.
  38. Li, F., Liu, K., Gray, C., Harris, P., Reynolds, C. M., Vickers, M. H., & Guan, J. (2020). Cyclic glycineproline normalizes systolic blood pressure in high-fat diet-induced obese male rats. Nutrition, Metabolism and Cardiovascular Diseases, 30(2), 339-346.
  39. Liang, Z. L., Zhang, X. Y., Wang, F., Zhang, K., Liu, H. F., & Liu, H. L. (2018). Understanding molecular mechanisms of Rhodiola rosea for the treatment of acute mountain sickness through computational approaches (a STROBE-compliant article). Medicine, 97(39).
  40. Lipinski, C. A. (2004). Lead-and drug-like compounds: the rule-of-five revolution. Drug Discovery Today: Technologies, 1(4), 337-341.
  41. Liu, X., Zhou, J., Zhang, T., Chen, K., Xu, M., Wu, L., Liu, J., Huang, Y., Nie, B., Shen, X., Ren, P., & Huang, X. (2021). Meranzin hydrate elicits antidepressant effects and restores reward circuitry. Behavioural Brain Research, 398, 112898. https://doi.org/10.1016/j.bbr.2020.112898
  42. MacLeod-Carey, D., Solis-Céspedes, E., Lamazares, E., & Mena-Ulecia, K. (2020). Evaluation of new antihypertensive drugs designed in silico using Thermolysin as a target. Saudi Pharmaceutical Journal, 28(5), 582-592.
  43. Majumder, S., Ghosh, A., Chakraborty, S., Saha, S., & Bhattacharya, M. (2021). Metabolomics affirms traditional alcoholic beverage raksi as a remedy for high-altitude sickness. Journal of Ethnic Foods, 8(1), 1-10.
  44. Majumder, S., Chakraborty, S., Ghosh, A., & Bhattacharya, M. (2022). The Himalayan ethnic beverage tongba with therapeutic properties in high-altitude illnesses and metabolomic similarities to Japanese sake. Acta Universitatis Sapientiae, Alimentaria, 15(1), 67-83.
  45. Majumder, S., Ghosh, A., Saha, S., Acharyya, S., Chakraborty, S., Subba, P., Nandi, S., Sarkar, S., & Bhattacharya, M. (2023). In vitro bioactivities and gastrointestinal simulation validate ethnomedicinal efficacy of five fermented kodo-based Himalayan traditional drinks and bioaccessibility of bioactive components. Food Production, Process and Nutrition (in press)
  46. Morris, G. M., Goodsell, D. S., Halliday, R. S., Huey, R., Hart, W. E., Belew, R. K., & Olson, A. J. (1998). Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. Journal of Computational Chemistry, 19(14), 1639-1662.
  47. Mortelmans, K., & Zeiger, E. (2000). The Ames Salmonella/microsome mutagenicity assay. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 455(1-2), 29-60.
  48. Natesh, R., Schwager, S. L., Sturrock, E. D., & Acharya, K. R. (2003). Crystal structure of the human angiotensin-converting enzyme–lisinopril complex. Nature, 421(6922), 551-554.
  49. Pajouhesh, H., and George R. Lenz. (2005). Medicinal chemical properties of successful central nervous system drugs. NeuroRx, 2, 541-553.
  50. Paramashivam, S. K., Elayaperumal, K., bhagavan Natarajan, B., devi Ramamoorthy, M., Balasubramanian, S., & Dhiraviam, K. N. (2015). In silico pharmacokinetic and molecular docking studies of small molecules derived from Indigofera aspalathoides Vahl targeting receptor tyrosine kinases. Bioinformation, 11(2), 73.
  51. Patel, D.K. (2022). Biological potential and therapeutic effectiveness of meranzin hydrate on intestinal motility. International Journal of Surgery, 100, p.106289.
  52. Polosa, R., & Blackburn, M. R. (2009). Adenosine receptors as targets for therapeutic intervention in asthma and chronic obstructive pulmonary disease. Trends in Pharmacological Sciences, 30(10), 528-535.
  53. Potts, R. O., & Guy, R. H. (1992). Predicting skin permeability. Pharmaceutical Research, 9, 663-669.
  54. Priest, B.T., & McDermott, J.S. (2015). Cardiac ion channels. Channels, 9(6), 352-359.
  55. Priya, R., Sumitha, R., Doss, C. G. P., Rajasekaran, C., Babu, S., Seenivasan, R., & Siva, R. (2015). Molecular docking and molecular dynamics to identify a novel human immunodeficiency virus inhibitor from alkaloids of Toddalia asiatica. Pharmacognosy Magazine, 11(Suppl 3), S414.
  56. Riaz, M. B., Khan, A. U., & Qazi, N. G. (2019). Pharmacological and computational evaluation of fig for therapeutic potential in hyperactive gastrointestinal disorders. BMC Complementary and Alternative Medicine, 19, 1-22.
  57. Riley, B. E., Lougheed, J. C., Callaway, K., Velasquez, M., Brecht, E., Nguyen, L., Shaler, T., Walker, D., Yang, Y., Regnstrom, K., & Diep, L. (2013). Structure and function of Parkin E3 ubiquitin ligase reveals aspects of RING and HECT ligases. Nature Communications, 4(1), p.1982.
  58. Rozwarski, D. A., Vilcheze, C., Sugantino, M., Bittman, R., & Sacchettini, J. C. (1999). Crystal structure of the Mycobacterium tuberculosis enoyl-ACP reductase, InhA, in complex with NAD+ and a C16 fatty acyl substrate. Journal of Biological Chemistry, 274(22), 15582-15589.
  59. Savioli, G., Ceresa, I. F., Gori, G., Fumoso, F., Gri, N., Floris, V., Varesi, A., Martuscelli, E., Marchisio, S., Longhitano, Y., & Ricevuti, G. (2022). Pathophysiology and therapy of high-altitude sickness: Practical approach in emergency and critical care. Journal of Clinical Medicine, 11(14), p.3937.
  60. Saxena, P., Hortigon‐Vinagre, M. P., Beyl, S., Baburin, I., Andranovits, S., Iqbal, S. M., Costa, A., IJzerman, A. P., Kügler, P., Timin, E., & Smith, G. L. (2017). Correlation between human ether‐a‐go‐go‐related gene channel inhibition and action potential prolongation. British Journal of Pharmacology, 174(18), 3081-3093.
  61. Scammell, T. E., Gerashchenko, D. Y., Mochizuki, T., McCarthy, M. T., Estabrooke, I. V., Sears, C. A., Saper, C. B., Urade, Y., & Hayaishi, O. (2001). An adenosine A2a agonist increases sleep and induces Fos in ventrolateral preoptic neurons. Neuroscience, 107(4), 653-663.
  62. Schyman, P., Liu, R., Desai, V., & Wallqvist, A. (2017). vNN web server for ADMET predictions. Frontiers in Pharmacology, 8, p.889.
  63. Sekiguchi, H., Takabayashi, F., Irie, K., & Murakami, A. (2012). Auraptene attenuates gastritis via reduction of Helicobacter pylori colonization and pro-inflammatory mediator production in C57BL/6 mice. Journal of Medicinal Food, 15(7), 658-663.
  64. Semwal, P., Painuli, S., Badoni, H., & Bacheti, R. K. (2018). Screening of phytoconstituents and antibacterial activity of leaves and bark of Quercus leucotrichophora A. Camus from Uttarakhand Himalaya. Clinical Phytoscience, 4, 1-6.
  65. Sharma, P. K., Suri, T. M., Venigalla, P. M., Garg, S. K., Mohammad, G., Das, P., Sood, S., Saraya, A., & Ahuja, V. (2014). Atrophic gastritis with high prevalence of Helicobacter pylori is a predominant feature in patients with dyspepsia in a high altitude area. Tropical gastroenterology : official journal of the Digestive Diseases Foundation, 35(4), 246–251. https://doi.org/10.7869/tg.224
  66. Sharma, R., Cramer, N. P., Perry, B., Adahman, Z., Murphy, E. K., Xu, X., Dardzinski, B. J., Galdzicki, Z., Perl, D. P., Dickstein, D. L., & Iacono, D. (2019). Chronic exposure to high altitude: synaptic, astroglial and memory changes. Scientific Reports, 9(1), p.16406.
  67. Singh, H. B., Prasad, P., & Rai, L.K. (2002). Folk medicinal plants in the Sikkim Himalayas of India. Asian Folklore Studies, 61, 295–310.
  68. Singh, L. C. G. (2017). High altitude dermatology. Indian Journal of Dermatology, 62(1), 59.
  69. Smith, C. J., Zhang, Y., Koboldt, C. M., Muhammad, J., Zweifel, B. S., Shaffer, A., Talley, J. J., Masferrer, J. L., Seibert, K., & Isakson, P. C. (1998). Pharmacological analysis of cyclooxygenase-1 in inflammation. Proceedings of the National Academy of Sciences, 95(22), 13313-13318.
  70. Te Riet, L., van Esch, J. H., Roks, A. J., van den Meiracker, A. H., & Danser, A. J. (2015). Hypertension: renin–angiotensin–aldosterone system alterations. Circulation research, 116(6), 960-975.
  71. Trott, O., & Olson, A. J. (2010). AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455-461.
  72. Trzaskowski, B., Latek, D., Yuan, S., Ghoshdastider, U., Debinski, A., & Filipek, S. (2012). Action of molecular switches in GPCRs-theoretical and experimental studies. Current Medicinal Chemistry, 19(8), 1090-1109.
  73. Willumsen, N. J., Bech, M., Olesen, S. P., Jensen, B. S., Korsgaard, M. P., & Christophersen, P. (2003). High throughput electrophysiology: new perspectives for ion channel drug discovery. Receptors and Channels, 9(1), 3-12.
  74. Yeerjiang, A., Maimaitiyiming, D., Yang, T., Fang, L., Aihemaitituoheti, A., Aimaiti, M., Zhang, X., & Nijiati, Y. (2023). Pomegranate Peel in the Amelioration of High-Altitude Disease: A Network Pharmacology and Molecular Docking Study of Underlying Mechanisms. Journal of Food Biochemistry, 2023, 7186747.
  75. Yi, H., Wang, K., Gan, X., Li, L., Zhang, Q., Xiang, J., Yuan, X., Zhang, Y., & Wang, Y. (2020). Prophylaxis of ibuprofen in acute mountain sickness: A protocol for systematic review and meta-analysis. Medicine, 99(46).
  76. Zhao, K., Xing, R., & Yan, X. (2021). Cyclic dipeptides: Biological activities and self‐assembled materials. Peptide Science, 113(2), e24202.
DOI: https://doi.org/10.2478/aucft-2023-0022 | Journal eISSN: 2344-150X | Journal ISSN: 2344-1496
Language: English
Page range: 261 - 292
Submitted on: Nov 6, 2023
|
Accepted on: Dec 4, 2023
|
Published on: Jan 11, 2024
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2024 Soumya Majumder, Sourav Chakraborty, Arindam Ghosh, Malay Bhattacharya, published by Lucian Blaga University of Sibiu
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.